Posters

Posters
15 October 2024
Considerations for AAV analytical comparability studies for products with low batch numbers
S M. Schermann, P Beck, M Hoerer
Poster #0220
Download
Posters
15 October 2024
Two for one: A single QC assay to quantify two plasmid impurities (cap/kanR) across a number of serotypes reduces time & costs for rAAV batch release
S. Beer, R. Kober, F. Thoennissen, M. Magerl, K. Breunig, F. Dunker-Seidler, R. Feiner, S. Geiger, S. Schermann
Poster #0197
Download
Posters
15 October 2024
Streamlined pre-formulation screening with minimal sample requirements & ​2-day turnaround to enable high efficiency ​AAV formulation development
Philipp Beck, Astrid Stockinger, Sonya M. Schermann
Poster #0157
Download
Posters
15 October 2024
Advancements in nanopore sequencing allow ​in-depth characterization of rAAV vector batches comparable to SMRT™ sequencing
K Breunig, F Dunker-Seidler, F Sonntag, M Hoerer, RC Feiner
Poster #0153
Download
Posters
15 October 2024
Qualification of an mRNA expression assay for GOI, stability insights, and process evolution detection
G. Iyer, S. Sleep
Poster #0097
Download
Posters
15 October 2024
Successful capture DoE studies for a range of AAV serotypes to reduce manufacturing costs & accelerate development
M. Langhauser, R. Staffler, J. Trommer, C. Mantzoros, M. Boscher, B. Larena Carnio, A. Youssef, K. Heller
Poster #0091
Download
Posters
15 October 2024
Development & qualification of potency assay : guidelines and strategy​
H. Naas, R. Dhambri, G. Iyer, S. Sleep
Poster #0068
Download
Posters
15 October 2024
Assessing device compatibility through assay matrix approach ensures therapeutic consistency & patient welfare
R. Dhambri, H. Naas, M. Sawyer, C. Salas, C. Jerome, G. Iyer, S. Sleep
Poster #0067
Download
Posters
15 October 2024
Nanopore sequencing grants detailed insights into a ​small molecule’s impact on encapsidated DNA​ composition during manufacturing platform development
Poster #0059
Download
Posters
15 October 2024
Successful validation of capsid titer and host-cell derived DNA impurity assays extends our rAAV batch release QC portfolio
Poster #0057
Download
Posters
15 October 2024
Modular, scalable AAV purification process for safe vectors & recoveries of up to 50%
Poster #0031
Download
Posters
20 May 2024
Combination of BMI, DLS and Visual Inspection to resolve particle formation issues in formulations commonly used in gene therapy
A Stockinger, P Beck, S M Schermann,
Download

Load more